drugset / Trial / NCT05145569
Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
In this study, the safety, tolerability, and anti-tumor activity of HCW9218 in combination with chemotherapy will be assessed in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy.
Timeline
- Start
- 2024-05-10
- Primary completion
- 2026-05-31
- Completion
- 2028-01-31
Outcome
Outcome not reported
Stopped: “Per PI and agent sponsor”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HCW9218 | Protein / enzyme biologic | — | — |
| Background | Carboplatin | Small molecule | 5 unknown | — |
| Background | Paclitaxel | Small molecule | 175 mg/m2 | — |